Status of Ongoing Proceedings

For information on how to obtain public transcripts of proceedings, please contact the Registrar, Riaz Awadia, by phone at 613-288-9597 or by e-mail at Riaz.Awadia@pmprb-cepmb.gc.ca.

Dates of Upcoming Hearings or Pre-Hearing Conferences

Case Event Date / Location
Procysbi – Horizon Therapeutics Canada Hearing

March 10 – 12, 2021

The Hearing will take place using the Zoom platform and will be livestreamed on YouTube.
To participate as an Observer, please send an email no later than 4:00pm on March 8, 2021 stating your name, email address and phone number to the Secretariat at Riaz.awadia@pmprb-cepmb.gc.ca

Matters before the Board

Excessive Pricing
Patented Drug Product Indication / Use Patentee Issue Date of Notice of Hearing Status
Procysbi nephropathic cystinosis Horizon Therapeutics Canada Allegations of excessive pricing February 27, 2019
Case Management

Judicial Review of Board Decisions and Appeals

Patented Drug Product Indication / Use Patentee Issue Date of Notice of Application Status

Soliris

Paroxysmal Nocturnal Hemoglobinuria

Atypical Hemolytic Uremic Syndrome

Alexion Pharmaceuticals Inc.

Allegations of excessive pricing

January 20, 2015

Court File A-237-19 (RE Appeal of Federal Court’s decision in T-1596-17 RE Board Panel’s decision of Sept 20, 2017)

  • Heard on October 20 & 21, 2020 (matter under reserve)

Differin
Differin XP

Acne

Galderma Canada Inc.

Failure to file (jurisdiction)

August 11, 2020

Court File T-906-20 (RE Board Panel’s decision of May 7, 2020)

  • Applicant filed affidavits on September 25, 2020

Other Court Proceedings Relevant to the PMPRB

Issue Applicant Respondent Court Status

Vires of amendments to Patented Medicines Regulations

Innovative Medicines Canada et al

Attorney General of Canada

Federal Court of Appeal

Court File A-215-20 (Appeal of Federal Court’s decision in T-1465-19)

  • Memoranda filed by both parties

Constitutionality of ss 79-103 of the Patent Act and the Patented Medicines Regulations

Merck Canada Inc et al

Attorney General of Canada

Court of Appeal of Quebec

Court File TBD (Appeal of Superior Court of Quebec’s decision in 500-17-109270-192)

  • Notice of Appeal filed January 25, 2021

Vires of Guidelines issued by the PMPRB

Innovative Medicines Canada et al

Attorney General of Canada

Federal Court

Court File T-1419-20 (RE Board’s Decision to issue Guidelines on October 23, 2020)

  • Notice of Application filed November 23, 2020
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: